Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans

PLoS Neglected Tropical Diseases

Volumn 6, Issue 3, 2012, Pages

  Zompi, Simona ^a   Montoya, Magelda ^b   Pohl, Marie O ^a   Balmaseda, Angel ^b   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Centro Nacional de Diagnostico y Referencia   (Nicaragua)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SYNDECAN 1; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ANIMAL CELL; ANTIBODY PRODUCING CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CHILD; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS 2; DENGUE VIRUS 3; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRESCHOOL CHILD; PRIMARY INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SECONDARY INFECTION; VIRUS NEUTRALIZATION; ANIMAL; BLOOD; DENGUE VIRUS; IMMUNOLOGY; LYMPHOCYTOSIS; NICARAGUA;

ADOLESCENT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; INFANT; LYMPHOCYTOSIS; MALE; NICARAGUA;

EID: 84859200054     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001568     Document Type: Article

References (63)

1. WHO (1997) Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control. Geneva WHO 2nd edition.
2. Gibbons RV, Vaughn DW, (2002) Dengue: an escalating problem. BMJ 324: 1563-1566.
3. WHO, (2009) Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva WHO New edition.
4. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, et al. (2011) Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity. PLoS Negl Trop Dis 5: e1397.
5. Gutierrez G, Standish K, Narvaez F, Perez MA, Saborio S, et al. (2011) Unusual dengue virus 3 epidemic in nicaragua, 2009. PLoS Negl Trop Dis 5: e1394.
6. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, et al. (2010) Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201: 5-14.
7. Balmaseda A, Sandoval E, Perez L, Gutierrez CM, Harris E, (1999) Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg 61: 893-897.
8. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio SI, et al. (2005) Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 73: 1063-1070.
9. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, et al. (2006) High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 11: 935-942.
10. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, et al. (1990) Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42: 179-184.
11. Rothman AL, (2010) Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 338: 83-98.
12. Sabin AB, (1952) Research on dengue during World War II. Am J Trop Med Hyg 1: 30-50.
13. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120: 653-669.
14. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, et al. (1997) Risk factors in dengue shock syndrome. Am J Trop Med Hyg 56: 566-572.
15. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, et al. (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6: e1000790.
16. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, et al. (2000) Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol 152: 793-799; discussion 804.
17. Kliks SC, Nimmanitya S, Nisalak A, Burke DS, (1988) Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38: 411-419.
18. Beaumier CM, Mathew A, Bashyam HS, Rothman AL, (2008) Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis 197: 608-617.
19. Imrie A, Meeks J, Gurary A, Sukhbataar M, Kitsutani P, et al. (2007) Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol 81: 10081-10091.
20. Mangada MM, Rothman AL, (2005) Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175: 2676-2683.
21. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9: 921-927.
22. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS, (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40: 444-451.
23. Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, et al. (2002) Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360: 310-312.
24. Kyle JL, Balsitis SJ, Zhang L, Beatty PR, Harris E, (2008) Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 380: 296-303.
25. Zompi S, Santich BH, Beatty PR, Harris E, (2011) Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-reactive B and T cells. J Immunol in revision.
26. Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, et al. (2010) CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol 185: 5405-5416.
27. Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, et al. (2009) A protective role for dengue virus-specific CD8+ T cells. J Immunol 182: 4865-4873.
28. McHeyzer-Williams LJ, McHeyzer-Williams MG, (2005) Antigen-specific memory B cell development. Annu Rev Immunol 23: 487-513.
29. Amanna IJ, Slifka MK, (2010) Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 236: 125-138.
30. Leyendeckers H, Odendahl M, Lohndorf A, Irsch J, Spangfort M, et al. (1999) Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol 29: 1406-1417.
31. Smith KG, Light A, Nossal GJ, Tarlinton DM, (1997) The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J 16: 2996-3006.
32. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545-551.
33. Balmaseda A, Guzman MG, Hammond S, Robleto G, Flores C, et al. (2003) Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol 10: 317-322.
34. Fernandez RJ, Vazquez S, (1990) Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz 85: 347-351.
35. Seah CL, Chow VT, Tan HC, Can YC, (1995) Rapid, single-step RT-PCR typing of dengue viruses using five NS3 gene primers. J Virol Methods 51: 193-200.
36. Kuan G, Gordon A, Aviles W, Ortega O, Hammond SN, et al. (2009) The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170: 120-129.
37. Shresta S, Kyle JL, Robert Beatty P, Harris E, (2004) Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 319: 262-273.
38. Ansarah-Sobrinho C, Nelson S, Jost CA, Whitehead SS, Pierson TC, (2008) Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology 381: 67-74.
39. Mattia K, Puffer BA, Williams KL, Gonzalez R, Murray M, et al. (2011) Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One In press.
40. Crotty S, Aubert RD, Glidewell J, Ahmed R, (2004) Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 286: 111-122.
41. Polack FP, Hoffman SJ, Crujeiras G, Griffin DE, (2003) A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat Med 9: 1209-1213.
42. Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, et al. (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15: 34-41.
43. Harris E, Roberts TG, Smith L, Selle J, Kramer LD, et al. (1998) Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol 36: 2634-2639.
44. Mathew A, West K, Kalayanarooj S, Gibbons RV, Srikiatkhachorn A, et al. (2011) B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis 204: 1514-1522.
45. Morbach H, Eichhorn EM, Liese JG, Girschick HJ, (2010) Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 162: 271-279.
46. Yozwiak NL, Skewes-Cox P, Stenglein M, Balmaseda A, Harris E, et al. (2012) Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep Sequencing. PLoS Negl Trop Dis In Press.
47. Nduati EW, Ng DH, Ndungu FM, Gardner P, Urban BC, et al. (2010) Distinct kinetics of memory B-cell and plasma-cell responses in peripheral blood following a blood-stage Plasmodium chabaudi infection in mice. PLoS One 5: e15007.
48. Salaman MH, (1970) Immunodepression by mammalian viruses and plasmodia. Proc R Soc Med 63: 11-15.
49. Baxendale HE, Johnson M, Stephens RC, Yuste J, Klein N, et al. (2008) Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol 151: 51-60.
50. Weill JC, Weller S, Reynaud CA, (2009) Human marginal zone B cells. Annu Rev Immunol 27: 267-285.
51. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, et al. (2004) Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
52. Weller S, Mamani-Matsuda M, Picard C, Cordier C, Lecoeuche D, et al. (2008) Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med 205: 1331-1342.
53. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, et al. (2008) Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3: e3942.
54. Halstead SB, Rojanasuphot S, Sangkawibha N, (1983) Original antigenic sin in dengue. Am J Trop Med Hyg 32: 154-156.
55. Midgley CM, Bajwa-Joseph M, Vasanawathana S, Limpitikul W, Wills B, et al. (2011) An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 85: 410-421.
56. van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, et al. (2010) Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers. J Infect Dis 202: 1002-1010.
57. Gromowski GD, Barrett AD, (2007) Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366: 349-360.
58. de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, et al. (2011) In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 5: e1188.
59. Vogt MR, Dowd KA, Engle M, Tesh RB, Johnson S, et al. (2011) Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fc-{gamma} receptor and complement-dependent effector mechanisms. J Virol 85: 11567-11580.
60. Kaufmann B, Vogt MR, Goudsmit J, Holdaway HA, Aksyuk AA, et al. (2010) Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proc Natl Acad Sci U S A 107: 18950-18955.
61. Alvarez M, Rodriguez-Roche R, Bernardo L, Vazquez S, Morier L, et al. (2006) Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg 75: 1113-1117.
62. Guzman MG, Kouri G, Valdes L, Bravo J, Vazquez S, et al. (2002) Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 11: 223-227.
63. Ohainle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, et al. (2011) Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 3: 114ra128.